FDA Drug recall D-0836-2020
Methylphenidate hydrochloride Extended-Release ablets USP (CII), 18 mg, 100-count bottle, Rx only, Teva Pharmaceuticals USA, Inc., North Wa…
- FDA Drug
- Class II
- terminated
- Published 2020-02-19
On 2020-02-19 the FDA classified a Class II recall of Methylphenidate hydrochloride Extended-Release ablets USP (CII), 18 mg, 100-count bottle, Rx only, Teva Pharmaceuticals USA, Inc., North Wa… by Teva Pharmaceuticals Usa, citing CGMP deviations: Product bottle may be absent of desiccant.
Read the official FDA Drug notice
| Agency | FDA Drug |
|---|---|
| Recall number | D-0836-2020 |
| Classification | Class II |
| Status | terminated |
| Initiated | 2020-01-27 |
| Published | 2020-02-19 |
| Last updated | 2026-09-13 11:52 UTC |
| Company | Teva Pharmaceuticals Usa |
| Distribution | US |
Product
Methylphenidate hydrochloride Extended-Release ablets USP (CII), 18 mg, 100-count bottle, Rx only, Teva Pharmaceuticals USA, Inc., North Wales, PA 19454, NDC 62037-725-01
Reason
CGMP deviations: Product bottle may be absent of desiccant.
Identifiers
| ndc | 62037-725-01 |
|---|---|
| ndc | 62037-734-01 |
| ndc | 62037-726-01 |
| ndc | 62037-727-01 |
| code_info | Lot #: 1332796 A, Exp 11/2020 |
Status history
No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:52 UTC. Current status: terminated.
Source
Official record: https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0836-2020%22
RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.